Skip to main content

Table 1 The characteristics of patients (n = 12)

From: Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway

Clinical characteristics

Patients (n, %)

Age (yr)

≤50

4 (33.3)

>50

8 (66.7)

Gender

Male

9 (75)

Female

3 (25)

BCLC stage

Stage 0-A

3 (25)

Stage B

7 (58.3)

Stage C-D

2 (16.7)

Etiology

Alcoholic

3 (25)

HBV

6 (50)

HCV

1 (8.3)

Others

2 (16.7)

Liver cirrhosis

No

2 (16.7)

Yes

10 (83.3)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us